Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Harpoon Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
HARP is no longer listed, so this page shows Q4 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 41
- +9 vs. Q3 2023
- Shares held
- 15.8M
- +13.9M (+744.9%) vs. Q3 2023
- Total value
- $175.5M
- +$167.9M (+2,229.2%) vs. Q3 2023
- New holders
- 16
- 14 more added
- Sold out
- 7
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HARP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 41 | $175.5M |
| Q3 2023 | 32 | $7.53M |
| Q2 2023 | 44 | $12.0M |
| Q1 2023 | 46 | $12.9M |
| Q4 2022 | 49 | $13.7M |
| Q3 2022 | 52 | $21.0M |
| Q2 2022 | 63 | $43.4M |
| Q1 2022 | 79 | $128.2M |
| Q4 2021 | 84 | $196.3M |
| Q3 2021 | 93 | $203.9M |
| Q2 2021 | 85 | $357.3M |
| Q1 2021 | 88 | $562.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Harpoon Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 2,349,060 | $22.6M | 1.08% | +2,295,000+4,245.3% | Added |
| New Leaf Venture Partners, L.L.C. | 1,859,168 | $21.1M | 17.03% | +1,543,500+489.0% | Added |
| Ra Capital Management, L.P. | 1,500,000 | $17.1M | 0.27% | +1,500,000 | New |
| Commodore Capital LP | 1,500,000 | $17.1M | 1.49% | +1,500,000 | New |
| Franklin Resources Inc | 1,492,368 | $17.0M | 0.01% | +1,360,041+1,027.8% | Added |
| Artal Group S.A. | 1,304,127 | $14.8M | 0.51% | +1,204,127+1,204.1% | Added |
| Vanguard Group Inc | 880,017 | $10.0M | 0.00% | +766,655+676.3% | Added |
| Soleus Capital Management, L.P. | 820,638 | $9.33M | 1.04% | +820,638 | New |
| Blackstone Group Inc. | 815,000 | $9.27M | 0.04% | +815,000 | New |
| Citadel Advisors LLC | 685,000 | $7.79M | 0.01% | +636,244+1,305.0% | Added |
| Ally Bridge Group (NY) LLC | 428,400 | $4.87M | 3.51% | +428,400 | New |
| MPM Oncology Impact Management LP | 319,670 | $3.63M | 0.85% | 00.0% | Unchanged |
| MPM Asset Management LLC | 313,136 | $3.56M | 1.75% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 300,000 | $3.41M | 0.01% | +300,000 | New |
| Sio Capital Management, LLC | 297,936 | $3.39M | 0.87% | +129,919+77.3% | Added |
| BlackRock Inc. | 249,834 | $2.84M | 0.00% | +212,895+576.3% | Added |
| Lion Point Capital, LP | 228,900 | $2.60M | 2.32% | +146,442+177.6% | Added |
| Geode Capital Management, LLC | 149,262 | $1.70M | 0.00% | +124,349+499.1% | Added |
| Kennedy Capital Management, Inc. | 52,160 | $593.1K | 0.01% | −827−1.6% | Reduced |
| Goldman Sachs Group Inc | 48,948 | $556.5K | 0.00% | +48,948 | New |
| Citigroup Inc | 39,222 | $446.0K | 0.00% | +39,222 | New |
| Two Sigma Investments, LP | 27,042 | $307.5K | 0.00% | +27,042 | New |
| Standard Life Aberdeen plc | 25,991 | $295.5K | 0.00% | +25,991 | New |
| Millennium Management LLC | 25,465 | $289.5K | 0.00% | +14,790+138.5% | Added |
| Northern Trust Corp | 24,080 | $273.8K | 0.00% | +24,080 | New |
| Renaissance Technologies LLC | 12,756 | $145.0K | 0.00% | −12,100−48.7% | Reduced |
| Charles Schwab Investment Management Inc | 11,401 | $129.6K | 0.00% | +11,401 | New |
| Caxton Corp | 13,176 | $129.3K | 0.70% | +13,176 | New |
| Cubist Systematic Strategies, LLC | 10,476 | $119.1K | 0.00% | +10,476 | New |
| BIT Capital GmbH | 7,407 | $84.2K | 0.01% | +7,407 | New |
| Bank of America Corp | 5,943 | $67.6K | 0.00% | +5,868+7,824.0% | Added |
| UBS Group AG | 2,608 | $29.7K | 0.00% | +2,554+4,729.6% | Added |
| Morgan Stanley | 252 | $2.87K | 0.00% | −219−46.5% | Reduced |
| Federation des caisses Desjardins du Quebec | 200 | $2.27K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 181 | $2.06K | 0.00% | +90+98.9% | Added |
| JPMorgan Chase & Co | 134 | $1.53K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 107 | $1.22K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 105 | $1.19K | 0.00% | +105 | New |
| Allworth Financial LP | 40 | $455 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 35 | $398 | 0.00% | −348−90.9% | Reduced |
| US Bancorp | 8 | $91 | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −62,121−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −7,670−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −706−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |